These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 14767445

  • 1. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA, Townley R, Casale TB.
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [Abstract] [Full Text] [Related]

  • 2. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.
    Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB.
    J Allergy Clin Immunol; 2003 Dec; 112(6):1147-54. PubMed ID: 14657874
    [Abstract] [Full Text] [Related]

  • 3. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis.
    Casale TB, Busse WW, Kline JN, Ballas ZK, Moss MH, Townley RG, Mokhtarani M, Seyfert-Margolis V, Asare A, Bateman K, Deniz Y, Immune Tolerance Network Group.
    J Allergy Clin Immunol; 2006 Jan; 117(1):134-40. PubMed ID: 16387596
    [Abstract] [Full Text] [Related]

  • 4. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
    Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D, Davancaze T, Adelman D.
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):243-8. PubMed ID: 15478383
    [Abstract] [Full Text] [Related]

  • 5. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy.
    Corren J, Shapiro G, Reimann J, Deniz Y, Wong D, Adelman D, Togias A.
    J Allergy Clin Immunol; 2008 Feb; 121(2):506-11. PubMed ID: 18269927
    [Abstract] [Full Text] [Related]

  • 6. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, van As A, Gupta N.
    J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.
    Eckman JA, Sterba PM, Kelly D, Alexander V, Liu MC, Bochner BS, Macglashan DW, Saini SS.
    J Allergy Clin Immunol; 2010 Apr; 125(4):889-895.e7. PubMed ID: 19962744
    [Abstract] [Full Text] [Related]

  • 11. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
    Ogino S, Nagakura T, Okubo K, Sato N, Takahashi M, Ishikawa T.
    Int Arch Allergy Immunol; 2009 Apr; 149(3):239-45. PubMed ID: 19218816
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):302-7. PubMed ID: 16464445
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST, Djukanović R, Casale T, Bousquet J.
    Clin Exp Allergy; 2005 Apr 08; 35(4):408-16. PubMed ID: 15836747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.